Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9H6R0
UPID:
DHX33_HUMAN
Alternative names:
DEAH box protein 33
Alternative UPACC:
Q9H6R0; B4DHF9; Q4G149; Q5CZ73; Q9H5M9
Background:
ATP-dependent RNA helicase DHX33, also known as DEAH box protein 33, plays a crucial role in nucleolar organization, ribosome biogenesis, and protein synthesis. It is essential for the transcription of 47S precursor rRNA, associating with ribosomal DNA loci to aid in POLR1A recruitment. Additionally, DHX33 is involved in the late stage of mRNA translation initiation, promoting the assembly of elongation-competent 80S ribosomes. Its ability to sense cytoplasmic dsRNA is vital for NLRP3 inflammasome formation in macrophages and type I interferon production in myeloid dendritic cells.
Therapeutic significance:
Understanding the role of ATP-dependent RNA helicase DHX33 could open doors to potential therapeutic strategies.